{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Medinova Diagnostic Services Ltd
Medinova Diagnostic Services Reports Stable Q3 FY24-25 Results Amid Score Adjustment
Medinova Diagno. Reports Consistent Revenue and Profit Growth, Low Debt Ratio
Medinova Diagno. has maintained a steady annual revenue of Rs 12.5 Cr in the last 3 years. The company's profit before tax has increased by 25% and net profit has improved by 20%, indicating a positive growth trend. With a low debt to equity ratio of 0.2, the company has a strong financial position and low risk for investors. MarketsMOJO has rated the stock as 'Sell', reflecting the company's stable financial performance. However, this is not a recommendation, but a neutral assessment based on the company's results. As a microcap company in the healthcare industry, Medinova Diagno. shows potential for growth and stability in the market. Investors should carefully consider all available information before making any investment decisions.
Medinova Diagnostic Services Reports Flat Financial Results for Q1 FY25, Continues to Provide Essential Healthcare Services
Medinova Diagnostic Services, a microcap healthcare company, reported a flat performance for the quarter ending June 2024. Despite this, the company remains a reliable player in the industry, offering a wide range of essential healthcare services. Its commitment to customer satisfaction and strong market presence make it a promising investment option for long-term investors.
Medinova Diagnostic Services Reports Flat Financial Performance, Stock Call Downgraded to 'Sell' by MarketsMOJO
Medinova Diagnostic Services, a microcap healthcare company, has reported flat financial results for the quarter ending March 2024. MarketsMOJO has downgraded the company's stock call to 'Sell'. Despite this, Medinova remains a key player in the industry, providing essential diagnostic services. Investors should conduct thorough research before making any investment decisions.
Medinova Diagnostic Services Reports Flat Financial Performance in Q4 2023
Medinova Diagnostic Services, a microcap healthcare company, reported flat financial results for Q4 of 2023. MarketsMOJO has given the company a 'Sell' rating, with a score drop from 1 to 0 in the past 3 months. Despite this, Medinova remains committed to providing quality healthcare services and aims to overcome its financial challenges through customer satisfaction and continuous improvement. Investors are advised to closely monitor the company's performance.
Medinova Diagnostic Services Ltd Continues to Outperform, But MarketsMOJO Calls for 'Sell' Rating
Medinova Diagnostic Services Ltd, a microcap healthcare services company, has been making waves in the Indian stock market with its recent performance. The stock has seen a consecutive 9-day gain streak, rising by 55.01%, and today hit a new 52-week high of Rs.64.5. Despite outperforming the sector, MarketsMOJO has given a 'Sell' call for the stock.
Medinova Diagnostic Services' Stock Reaches All-Time High, Rated as 'Sell' by MarketsMOJO
Medinova Diagnostic Services, a microcap company in the healthcare services industry, has seen a surge in its stock price, reaching an all-time high on January 8th, 2024. Despite being rated as a 'Sell' by MarketsMOJO, the stock has shown a consecutive gain of 55.01% in the past 9 days and is currently trading higher than its moving averages. Investors should do thorough research before making any investment decisions.
Medinova Diagnostic Services Surges with 4.99% Gain, Outperforms Sector and Sensex
Medinova Diagnostic Services, a microcap company in the healthcare services industry, has been gaining attention in the stock market. Despite being given a 'Sell' call by MarketsMOJO, the stock has been on a consecutive 8-day gain, reaching a new 52-week high and outperforming the sector. It is currently trading above its moving averages and has outperformed the Sensex in the past month. Investors should conduct their own research before making any investment decisions.
Adani Ports Shows Short-Term Strength Amid Mixed Long-Term Outlook in Competitive Market
Adani Ports & Special Economic Zone experienced significant trading activity, outperforming the sector and the Sensex. The stock's intraday high indicates short-term strength, although it remains below several longer-term moving averages. Over the past month, it has faced a decline, contrasting with the broader market's performance.
Adani Ports Shows Short-Term Strength Amid Mixed Long-Term Outlook in Competitive Market
Adani Ports & Special Economic Zone experienced significant trading activity, outperforming the sector and the Sensex. The stock's intraday high indicates short-term strength, although it remains below several longer-term moving averages. Over the past month, it has faced a decline, contrasting with the broader market's performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
Medinova Diagnostic Services Defies 'Sell' Call, Continues to Outperform Market
Medinova Diagnostic Services, a microcap healthcare services company, has been gaining attention in the stock market with a remarkable 47.63% increase in returns over the last 8 days. Despite a 'Sell' call from MarketsMOJO, the stock has outperformed the sector and is currently trading higher than its moving averages. It has also shown strong growth compared to the overall market performance.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}